Point of Care Diagnostics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

Technical developments like downsizing, lab-on-a-chip technologies, and artificial intelligence (AI) integration are expected to propel the market's exponential growth. These developments will increase POC devices' sensitivity, accuracy, and adaptability, making them more widely available and practical in a range of healthcare contexts, including home-based care. About 38.4 million Americans have diabetes, according to data from 2021 released by the Centers for Disease Control and Prevention (CDC).

Growth Drivers for the Point of Care Diagnostics Market

Numerous developments in technology

The development of the point-of-care diagnostics industry is greatly aided by technological advancements and integration. Numerous intelligent and portable diagnostic tools and systems are being developed as a result of initiatives and research in miniaturization, biosensors, and networking. These POC devices are capable of carrying out a variety of tests with a high degree of precision, something that conventional laboratory-based techniques frequently fall short of. In order to minimize turnaround time for test results and do away with the necessity for several devices, they are frequently combined with enlarged test options.

Additionally, businesses intend to create POC diagnostics systems that are small and provide extensive testing capabilities. In an effort to transform healthcare delivery, major industry players are also working with other businesses to provide distinctive and trustworthy diagnostic solutions. In 2023, Molbio Diagnostics and SigTuple announced their collaboration to create next-generation portable devices with AI capabilities for a variety of routine and diagnostic testing.

Personalized medicine's increasing importance

The market is expanding as a result of the public's growing need for individualized medicine. In order to investigate the efficacy of treating adults and children with different innovative drug combinations, the National Cancer Institute (NCI) has started a sizable precision medicine cancer effort.

Furthermore, the use of customized medicine is making it easier to develop treatment programs that are tailored to the needs of patients as the healthcare industry shifts to a more patient-centric approach. POC diagnostics are essential to this process because they provide quick and focused diagnostic answers that support accurate illness detection and tracking. They give patients confidence about their care and general well-being, which contributes to their high level of patient acceptability. Furthermore, Coriell Life Sciences' research confirms that precision medicine has reached a tipping point for adoption on a worldwide scale.

The rising incidence of long-term illnesses

The World Health Organization (WHO) estimates that 41 million people die from non-communicable diseases, commonly referred to as chronic diseases, each year, accounting for 74% of all deaths worldwide. The need for POC diagnostic services is being driven by the increase in chronic diseases worldwide. The prevalence of chronic illnesses including diabetes, heart disease, and respiratory ailments is rising, which presents significant problems for healthcare systems around the globe. POC diagnostics are a useful instrument for the impromptu identification and ongoing surveillance of various health issues, enabling prompt interventions and efficient disease control. POC testing's accessibility and ease of use also aid in the management of chronic illnesses, particularly in rural or isolated locations with limited or nonexistent access to conventional laboratory facilities. Therefore, the demand for point-of-care diagnostics worldwide is being driven by the rising prevalence of chronic diseases.

Challenges in the Point of Care Diagnostics Market

Adoption of the Devices May Be Limited by Point of Care Tests' Inaccuracy

Because of their many benefits, POC testing kits and devices are becoming more and more popular in the market. There are certain restrictions, nevertheless, including the low accuracy of test results obtained with POC kits and devices. Another significant obstacle to the limited population adoption of these tests is the expensive cost of the technologies. Due to inadequate connectivity caused by developing nations' inadequate healthcare infrastructure, patient medical records must be manually entered into the system, which can lead to mistakes, delays, and redundant testing, all of which raise the testing's expenses.

Therefore, during the forecast period, the growing cost of the devices and their lack of precision are anticipated to impede the worldwide market's growth.

Regulatory and Quality Assurance in Low-Resource Settings

It might be difficult to maintain the necessary regulatory and quality assurance standards for Point of Care (POC) diagnostics in environments with limited resources. These settings frequently lack the regulatory monitoring, skilled workers, and infrastructure required to guarantee the accuracy and dependability of the devices. It becomes challenging to maintain constant quality control, calibration, and adherence to safety procedures, which could result in erroneous test findings and erode patient confidence. The use of POC devices may be made more difficult by regulatory bodies' inability to monitor and enforce compliance in certain areas. Furthermore, it is more difficult to invest in continuous training, quality assurance, or device certifications in these environments due to a lack of funding. POC technologies may therefore be reluctantly adopted by healthcare professionals in low-resource locations, limiting their potential influence in these markets.

Glucose monitoring kits are a leading segment in point-of-care diagnostics

Glucose monitoring kits are among the broadly applied products in the global point-of-care diagnostics market. This is attributed to their essential role in coping with diabetes, a universal worldwide occurrence. These kits enable people to easily monitor their blood glucose levels, allowing for timely adjustments to medication and lifestyle. With the growing prevalence of diabetes and the emphasis on self-control, glucose monitoring kits have ended up as quintessential equipment for sufferers, caregivers, and healthcare experts, propelling their widespread adoption.

Lateral flow technology is expected to lead the point-of-care diagnostics market

Lateral Flow technology is one of the dominating sections in the global point-of-care diagnostics market. This is due to its simplicity, rapidity, and flexibility. These tests provide brief effects without requiring a specialized system, making them perfect for decentralized settings. With applications ranging from pregnancy checks to infectious ailment detection, they address diverse diagnostic needs effectively. Their low cost and ease of use make them available in resource-constrained environments. As demand for convenient and reliable testing solutions surges, lateral flow technology remains a cornerstone in point-of-care diagnostics.

Over-the-counter devices significantly drive growth in the global POC diagnostics market

Over-the-counter (OTC) devices drastically contribute to the global factor-of-care diagnostics market because of their accessibility and convenience. These user-friendly tests empower individuals to monitor their health without needing expert intervention or prescription. With an extensive range of OTC options to be had for conditions like being pregnant, ovulation tracking, and infectious sicknesses, consumers can quickly achieve outcomes in the consolation of their houses. As healthcare trends toward self-control and preventive care, OTC-based devices are vital in promoting proactive health monitoring. This is driving their considerable contribution to the point-of-care diagnostics market.

Professional diagnostic centers are key users in the global POC diagnostics market

Professional Diagnostic Centers are some of the most broadly used in the point-of-care diagnostics market. This is because of their comprehensive testing abilities and understanding. These centers offer diverse diagnostic offerings, including complicated tests and consultations, ensuring accurate and reliable consequences. Their advanced device and skilled employees provide a dependent resource for healthcare specialists and sufferers seeking thorough diagnostic opinions.

Point of Care Diagnostics Market Overview by Regions

North America (the United States and Canada), Europe (France, Germany, Italy, Spain, the United Kingdom, Belgium, the Netherlands, and Turkey), Asia Pacific (China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, and New Zealand), Latin America (Brazil, Mexico, and Argentina), and the Middle East and Africa (Saudi Arabia, the United Arab Emirates, and South Africa) comprise the various regions that make up the global point-of-care diagnostics market. The market for point-of-care diagnostics is expected to be led by the United States. This is because more and more people are suffering from chronic illnesses and infectious diseases.

United States Point of Care Diagnostics Market

The market for Point of Care (POC) diagnostics in the US is expanding significantly due to rising demand for quick, on-site testing and technological developments. POC devices improve patient care and decrease hospital visits by enabling fast results for a variety of disorders, such as diabetes, cardiovascular diseases, infectious diseases, and pregnancy. An aging population, an increase in the incidence of chronic illnesses, and rising consumer desire for affordable, easily accessible healthcare solutions all help the industry. Additionally, the market is expanding due to the growing use of home testing kits and over-the-counter (OTC) diagnostic products. Nonetheless, the market is still impacted by obstacles like payment concerns, data integration with healthcare systems, and regulatory compliance. The United States continues to lead the world in POC diagnostic innovation and application in spite of these obstacles.

The ADEXUSDx hCG Test from NOWDiagnostic was approved by the USFDA in May 2022 and made accessible in the US for the qualitative detection of human chorionic gonadotropin (hCG) in human whole blood, plasma, or serum. Healthcare workers in a range of clinical and critical care settings can use this immunoassay test as an early pregnancy screening tool. Therefore, regulatory bodies' approval of new POC diagnostics is helping the market under study expand in the area.

Germany Point of Care Diagnostics Market

The growing need for quick, on-site diagnostic solutions and improvements in medical technology are driving the steady growth of the Point of Care (POC) diagnostics market in Germany. The need for POC devices is mostly driven by Germany's elderly population and well-established healthcare system, particularly for ailments like diabetes, cardiovascular disease, and infectious diseases. A strong emphasis on early disease identification and preventative healthcare, which POC devices provide, supports the market. The industry is also expanding as a result of the popularity of over-the-counter (OTC) diagnostics and home testing kits. Nonetheless, issues including reimbursement guidelines, regulatory compliance, and the requirement for smooth data integration with current healthcare systems continue to remain. Germany continues to play a significant role in the European POC diagnostics industry in spite of these obstacles, thanks to its innovative healthcare infrastructure.

India Point of Care Diagnostics Market

India's market for point-of-care diagnostics is expanding quickly due to the country's vast population, growing healthcare needs, and the prevalence of chronic illnesses like diabetes, heart disease, and infectious diseases. POC diagnostics are quite popular in impoverished and rural areas with little access to medical institutions because they provide fast, affordable, and accurate results. Additional factors driving market growth include government programs to increase access to healthcare, rising awareness of preventative care, and the emergence of home testing options. Demand is also being fueled by the uptake of mobile health technologies and reasonably priced diagnostic tools. But there are still issues like quality control, regulatory complexity, and data integration with healthcare systems. Notwithstanding these obstacles, the POC diagnostics market in India is still expanding thanks to advancements in technology and bettering healthcare facilities.

In January 2023, for example, Cipla Limited, an Indian company, introduced Cippoint, a point-of-care (POC) testing tool that provides a variety of diagnostic parameters, including thyroid function, diabetes, cardiac markers, fertility, infectious diseases, inflammation, coagulation markers, and metabolic markers.

Saudi Arabia Point of Care Diagnostics Market

The Saudi Arabian point-of-care diagnostics market is developing as a result of improvements in medical technology, rising healthcare demand, and an increased emphasis on preventative treatment. Rapid and precise diagnostics are crucial since the nation's huge and diversified population is experiencing an increase in the prevalence of chronic diseases like diabetes, heart disease, and respiratory disorders. Quick results from POC devices allow for prompt treatment and lower hospital visits. The adoption of POC solutions is further encouraged by government programs like Vision 2030, which place an emphasis on the modernization and accessibility of the healthcare sector. The market is also expanding due to the rising demand for mobile health solutions and home testing kits. Regulatory obstacles and guaranteeing device accuracy are still problems, though. In spite of this, the POC diagnostics market in Saudi Arabia exhibits encouraging growth prospects.

Products – Market breakup in 9 viewpoints:

1.    Glucose Monitoring Kits
2.    Infectious Diseases Kits
3.    Pregnancy & Fertility Testing Kits
4.    Haematology Testing Kits
5.    Cardiometabolic Monitoring Kits
6.    Urinalysis Testing Kits
7.    Cholesterol Test Strips
8.    Drugs Abuses Testing Kits
9.    Others

Technology – Market breakup in 6 viewpoints:

1.    Lateral Flow
2.    Agitation
3.    flow through
4.    solid phase
5.    biosensor
6.    Others

Point of prescription – Market breakup in 2 viewpoints:

1.    Prescription-Based Devices
2.    Over-the-counter (OTC)-Based Devices

End-User – Market breakup in 4 viewpoints:

1.    Professional Diagnostic Centers
2.    Research Laboratories
3.    Home Care
4.    Others

Country – Market breakup of 25 Countries:

1.    North America

1.1    United States
1.2    Canada

2.    Europe

2.1    France
2.2    Germany
2.3    Italy
2.4    Spain
2.5    United Kingdom
2.6    Belgium
2.7    Netherlands
2.8    Turkey

3.    Asia Pacific

3.1    China
3.2    Japan
3.3    India
3.4    South Korea
3.5    Thailand
3.6    Malaysia
3.7    Indonesia
3.8    Australia
3.9    New Zealand

4.    Latin America

4.1    Brazil
4.2    Mexico
4.3    Argentina

5.    Middle East & Africa

5.1    Saudi Arabia
5.2    UAE
5.3    South Africa

All the Key players have been covered from 3 Viewpoints:

•    Overview
•    Recent Development
•    Revenue Analysis

Company Analysis:

1.    Sysmex
2.    Abbott Laboratories (US)
3.    Becton Dickinson and Company (US)
4.    Danaher Corporation (US)
5.    Quidel Diagnostics (US)
6.    F. Hoffmann-La Roche Ltd
7.    Thermo Fisher Scientific Inc.
8.    Bio-Rad Laboratories Inc.

Report Details: